2 ms·
1) the glowing plant project isn't doing that great. There have been scant technical updates to their blog, despite the promises of their founders, and they've
by dnautics 13y ago
1) the glowing plant project isn't doing that great. There have been scant technical updates to their blog, despite the promises of their founders, and they've quietly pushed the delivery date from April to July.
2) the ability to print large quantities of DNA for a given patient is not really going to be necessary. For the most part any "biologic" drug that might need to be personalized is most likely going to be 99% common "boilerplate" plus 1% or less "personalization". For example, antibodies, which have a massive common region plus a small amount of variable region that is an 'adapter' to whatever you're going to use the antibody for. We are well, well within the ability to synthesize this amount of DNA at an affordable cost, and have been for a while. Not to mention that you'll still be giving 'the same drug' to more than one person, that's because human variation is not that high (especially everywhere except for africa due to population bottlenecks in human migration).
3) The point about the netflix model is an interesting one.